RARE-05. PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IN IMMUNOCOMPROMISED HOSTS – A SINGLE INSTITUTION RETROSPECTIVE STUDY (2002-2017) [PDF]
Leon D. Kaulen +5 more
openalex +1 more source
Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara +3 more
wiley +1 more source
Pulmonary mucormycosis and <i>Achromobacter xylosoxidans</i> co-infection in an immunocompromised host: a case report. [PDF]
Subedi B +4 more
europepmc +1 more source
Bordetella trematum bacteraemia secondary to an empyema in an immunocompromised host: A case report and review of the literature. [PDF]
Wong C, Calungsud LG, La MV.
europepmc +1 more source
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino +10 more
wiley +1 more source
A Hitchhiker’s Guide to the BK Galaxy
Hans H. Hirsch, Camille N. Kotton
doaj +1 more source
Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy. [PDF]
Hayek H +8 more
europepmc +1 more source
SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing. [PDF]
Seth-Smith H +3 more
europepmc +1 more source
A Rare Form of Invasive Aspergillus Infection in a Severely Immunocompromised Host [PDF]
Salim Daouk +2 more
openalex +1 more source
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot +3 more
wiley +1 more source

